ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PETS vs GRDN // FORWARD P/E MULTIPLE

PetMed Express Inc. (NASDAQ) VS. Guardian Pharmacy Services Inc. (Class A) (NYSE) • 15-METRIC TALLY: PETS 2 — GRDN 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PETS VS. GRDN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PETS GRDN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 28.10% 20.20% +7.90 PETS /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 37.70% -72.70 GRDN /roic <GO>
EV/EBITDA & P/E Valuation — 34.3x — TIE /valuation <GO>
Free Cash Flow Yield — 3.91% — TIE /fcf-yield <GO>
Operating Margin -32.80% 5.00% -37.80 GRDN /operating-margins <GO>
Net Profit Margin -32.00% 3.40% -35.40 GRDN /net-margins <GO>
Revenue Growth (YoY) -21.10% 17.90% -39.00 GRDN /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.08% 0.00% +0.08 PETS /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.24 12.39 -12.15 GRDN /balance-sheet <GO>
Piotroski F-Score Quality 2/9 7/9 -5.00 GRDN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.1 50.6 -16.46 GRDN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — 43.8x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $25.6M $2.56B -$2.54B GRDN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PETS REV GRDN REV PETS GROSS % GRDN GROSS % PETS FCF GRDN FCF
FY 2025 $179.0M $1.45B 28.1% 20.2% -$33.0M $100.3M
FY 2024 $227.0M $1.23B 30.5% 19.9% -$395.0K $58.0M
FY 2023 $274.1M — — — $4.3M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PETS // BETA —
GRDN // BETA —